Time-varying pattern of recurrence risk for gastric cancer patients

被引:27
作者
Feng, Xing-Yu [1 ,2 ]
Chen, Ying-Bo [1 ,2 ]
Wang, Wei [1 ,2 ]
Guan, Yuan-Xiang [1 ,2 ]
Li, Yuan-Fang [1 ,2 ]
Chen, Shi [1 ,2 ]
Sun, Xiao-Wei [1 ,2 ]
Li, Wei [1 ,2 ]
Xu, Da-Zhi [1 ,2 ]
Zhan, You-Qing [1 ,2 ]
Zhang, Xiao-Shi [1 ,3 ]
Zhou, Zhi-Wei [1 ,2 ]
机构
[1] State Key Lab Oncol South China, Guangzhou 510060, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Ctr Canc, Dept Gastr & Pancreat Surg, Guangzhou 510060, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Ctr Canc, Biotherapy Ctr, Guangzhou 510060, Guangdong, Peoples R China
关键词
Gastric cancer; Recurrence risk; Tumor dormancy; BREAST-CANCER; GASTRECTOMY; DORMANCY;
D O I
10.1007/s12032-013-0514-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study analyzed the time-varying pattern of the recurrence risk for gastric cancer after surgery. A total of 1,222 gastric patients undergoing D2 resection surgery were studied retrospectively. The annual recurrence hazard curve for all of the populations showed one early peak and a late rise within 10 years after the surgery. The first major recurrence peak covers the first 3 years after the surgery, rising to a maximum at 1.5 years after surgery, followed by a decline until 7.5 years after the surgery, at which point the curve began to rise again. A subgroup analysis of this pattern also revealed that the curves of the patients with bigger tumors, poorly differentiated/undifferentiated adenocarcinomas, lymphatic/venous invasion, T3 and T4, node positive or with fewer lymph nodes retrieved were steeper. Chemotherapy can reduce the hazard rate for recurrence of gastric cancer. Our study confirms the time-varying pattern of the recurrence risk for gastric cancer, and it further supports the hypothesis of tumor dormancy after surgery. To effectively reduce the recurrence risk, new adjuvant therapies beyond chemotherapy may be needed.
引用
收藏
页数:5
相关论文
共 16 条
[1]   Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial [J].
Bang, Yung-Jue ;
Kim, Young-Woo ;
Yang, Han-Kwang ;
Chung, Hyun Cheol ;
Park, Young-Kyu ;
Lee, Kyung Hee ;
Lee, Keun-Wook ;
Kim, Yong Ho ;
Noh, Sang-Ik ;
Cho, Jae Yong ;
Mok, Young Jae ;
Kim, Yeul Hong ;
Ji, Jiafu ;
Yeh, Ta-Sen ;
Button, Peter ;
Sirzen, Florin ;
Noh, Sung Hoon .
LANCET, 2012, 379 (9813) :315-321
[2]   Clinicopathologic Characteristics of Gastric Cancer Patients according to the Timing of the Recurrence after Curative Surgery [J].
Choi, Ji Yoon ;
Ha, Tae Kyung ;
Kwon, Sung Joon .
JOURNAL OF GASTRIC CANCER, 2011, 11 (01) :46-54
[3]   Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: Further support about the concept of tumor dormancy [J].
Demicheli, R ;
Abbattista, A ;
Miceli, R ;
Valagussa, P ;
Bonadonna, G .
BREAST CANCER RESEARCH AND TREATMENT, 1996, 41 (02) :177-185
[4]   Tumour dormancy: findings and hypotheses from clinical research on breast cancer [J].
Demicheli, R .
SEMINARS IN CANCER BIOLOGY, 2001, 11 (04) :297-305
[5]   DORMANCY OF MICROMETASTASES - BALANCED PROLIFERATION AND APOPTOSIS IN THE PRESENCE OF ANGIOGENESIS SUPPRESSION [J].
HOLMGREN, L ;
OREILLY, MS ;
FOLKMAN, J .
NATURE MEDICINE, 1995, 1 (02) :149-153
[6]   RESULTS OF SURGERY ON 6589 GASTRIC-CANCER PATIENTS AND IMMUNOCHEMOSURGERY AS THE BEST TREATMENT OF ADVANCED GASTRIC-CANCER [J].
KIM, JP ;
KWON, CJ ;
OH, ST ;
YANG, HK ;
COHN, I ;
WANEBO, HJ .
ANNALS OF SURGERY, 1992, 216 (03) :269-279
[7]   SMOOTHING COUNTING PROCESS INTENSITIES BY MEANS OF KERNEL FUNCTIONS [J].
RAMLAUHANSEN, H .
ANNALS OF STATISTICS, 1983, 11 (02) :453-466
[8]   Annual hazard rates of recurrence for breast cancer after primary therapy [J].
Saphner, T ;
Tormey, DC ;
Gray, R .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (10) :2738-2746
[9]   Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage [J].
Schwarz, Roderich E. ;
Smith, David D. .
ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (02) :317-328
[10]  
Shiraishi N, 2000, CANCER-AM CANCER SOC, V89, P255, DOI 10.1002/1097-0142(20000715)89:2<255::AID-CNCR8>3.0.CO